The Effect of a Medicaid Drug Copayment Program on the Utilization and Cost of Prescription Services

The effect of a copayment for pharmaceutical services in a Medicaid program is presented. Data were collected from Medicaid claim files in South Carolina (experimental program) and Tennessee (control program) for a 4-year period, 1976-1979. Utilization rates and expenditures for 1 year prior to copayment and 3 years after copayment were computed from a stratified sample of 18 counties. Both the level of prescriptions per eligible recipient and the slope of the utilization function after copayment were found to have declined with the implementation of copayment in South Carolina. The level of the expenditure series after copayment also declined, but the series retained a positive trend. Subsequent analysis of prescription quantity concluded that the increasing expenditure function was attributed to the inflation in cost of ingredients rather than an increase in average prescription size. The study concluded that a small (50) copayment for prescription service is a successful mechanism to control the cost and assist in financing a Medicaid prescription drug program

Copayment · Economics · Family medicine · Health care · Health insurance · Medicaid · Medical prescription · Healthcare Policy and Management · Medication Adherence and Compliance · Medicine · Nursing · Pharmaceutical Economics and Policy

• The seed of abundance and misery

  Open Access•Linda Twrdek, Kerstin Manzel•Economics & Human Biology•2010

  Incluir item

• Are Prescribed and Over-the-Counter Medicines Economic Substitutes

  Bruce Stuart, James Grana•Medical Care•1995

  Incluir item

• A Copayment Increase for Prescription Drugs

  Open Access•Teresa B Gibson, CATHERINE G MCLAUGHLIN et al.•INQUIRY The Journal of Health…•2005

  Incluir item

• Socioeconomic Position and Health among Persons with Diabetes Mellitus

  Arleen F Brown•Epidemiologic Reviews•2004

  Incluir item

• Adverse Events Associated With Prescription Drug Cost-Sharing Among Poor and Elderly Persons

  Robyn Tamblyn•JAMA•2001

  Incluir item

• What impact do prescription drug charges have on efficiency and equity? Evidence from high-income countries

  Open Access•Marin Gemmill, Marin C Gemmill et al.•International Journal for Equity…•2008

  Incluir item

• A conceptually based approach to understanding chronically ill patients’ responses to medication cost pressures

  Open Access•John D Piette, Michele Heisler et al.•Social Science & Medicine•2006

  Incluir item

• The Effect of Increased Prescription Drug Cost-Sharing on Medical Care Utilization and Expenses of Elderly Health Maintenance Organization Members

  Richard E Johnson, Michael J Goodman et al.•Medical Care•1997

  Incluir item

• On Becoming 65 in Ontario

  Paul Grootendorst, Paul V Grootendorst Paul V Grootendorst et al.•Medical Care•1997

  Incluir item

• Effect of Increased Copayments on Pharmacy Use in the Department of Veterans Affairs

  Kevin T Stroupe, Bridget Smith et al.•Medical Care•2007

  Incluir item

• Knowledge of Health Care Benefits Among Patients With Depression

  Lisa S Meredith, Nicole Humphrey et al.•Medical Care•2002

  Incluir item

• Impact of a Medicaid Copayment Policy on Prescription Drug and Health Services Utilization in a Fee-for-Service Medicaid Population

  Daniel M Hartung, Matthew J Carlson et al.•Medical Care•2008

  Incluir item

• Effect of a Three-Tier Prescription Copay on Pharmaceutical and Other Medical Utilization

  Brenda Motheral, Brenda R Motheral et al.•Medical Care•2001

  Incluir item

• Unintended Consequences of a Medicaid Prescription Copayment Policy

  Daniel A Lieberman, Jennifer M Polinski et al.•Medical Care•2014

  Incluir item

• Ability to Pay and the Decision to Medicate

  Bruce Stuart, James Grana•Medical Care•1998

  Incluir item

• Increasing Patient Charges in the National Health Service

  Open Access•Stephen Birch, Birch•Journal of Social Policy•1986

  Incluir item

• Is magnitude of co-payment effect related to income? Using census data for health services research

  Open Access•Daniel C Cherkin, Louis Grothaus et al.•Social Science & Medicine•1992

  Incluir item

• Moral hazard and prescription medicine use in Australia-the patient perspective

  Open Access•Evan Doran, Jane Robertson et al.•Social Science & Medicine•2005

  Incluir item

• Charging for health care

  Open Access•Mandy Ryan, Stephen Birch•Social Science & Medicine•1991

  Incluir item

• Copayments for Ambulatory Care

  Milton I Roemer, Carl E Hopkins et al.•Medical Care•1975

  Incluir item